Company:  COOPER COMPANIES INC (COO)
Form Type:  10-K
Filing Date:  12/20/2013 
CIK:  0000711404 
Address:  6140 STONERIDGE MALL RD
STE 590
 
City, State, Zip:  PLEASANTON, California 94588 
Telephone:  (925) 460-3600 
Fiscal Year:  10/31 
Last Trade
Last Trade: 
$157.20  
Change: 
1.07 (0.69%)  
Trade Time: 
Oct 24  
Market Cap: 
$7.59B
Description of Business
The Cooper Companies, Inc. (Cooper, we or the Company), a Delaware corporation organized in 1980, is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life CompanyTM with a focus on shareholder value. Cooper operates through two business units, CooperVision, Inc. and CooperSurgical, Inc. CooperVision is a global manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a broad range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision's products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness; with a broad collection of spherical, toric and multifocal contact lenses. CooperVision's products are primarily manufactured at its facilities located in Hampshire, United Kingdom, Juana Diaz, Puerto Rico, and Scottsville, New York.
Register for EDGAR Pro and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business.
    NEW YORK STOCK EXCHANGE CERTIFICATION
    Item 1A. Risk Factors.
    Item 1B. Unresolved Staff Comments.
    PART I
      Item 2. Properties.
      Item 3. Legal Proceedings.
      Item 4. Submission of Matters to a Vote of Security Holders.
    PART II
      Item 5. Market for Registrant's Common Equity and Related ...
      Item 6. Selected Financial Data.
        INCOME STATEMENT
      Item 7. Management's Discussion and Analysis of Financial ...
        RESULTS OF OPERATIONS
        CAPITAL RESOURCES AND LIQUIDITY
      Item 7A. Quantitative and Qualitative Disclosure about ...
      Item 8. Financial Statements and Supplementary Data.
        Report of Independent Registered Public Accounting Firm
        INCOME STATEMENT
        INCOME STATEMENT
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to Consolidated Financial Statements
          INCOME STATEMENT
      Item 9. Changes In and Disagreements With Accountants on ...
      Item 9A. Controls and Procedures.
      Item 9B. Other Information.
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance.
      Item 11. Executive Compensation.
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accounting Fees and Services.
    PART IV
      Item 15. Exhibits and Financial Statement Schedules.
    Report of KPMG LLP, Independent Registered Public Accounting ...
    VALUATION AND QUALIFYING ACCOUNTS
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 10.2
  EXHIBIT 10.23
  EXHIBIT 21
  EXHIBIT 23
    Consent and Report on Schedule of Independent Registered ...
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
BROKERAGE PARTNERS